Covenant Asset Management, LLC Ligand Pharmaceuticals Inc Transaction History

Covenant Asset Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 26, 2019	SELL	$105.93 - $142.47 $1.1 Million - $1.48 Million	-10,374 Closed	0 $0
Q3 2018 Oct 09, 2018	SELL	$211.18 - $274.49 $8,447 - $10,979	-40 Reduced 0.38%	10,374 $2.85 Million
Q2 2018 Jul 12, 2018	BUY	$150.77 - $207.98 $1.57 Million - $2.17 Million	10,414 New	10,414 $2.16 Million

280

19M

9.5K

8.1K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.94B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Covenant Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Covenant Asset Management, LLC with notifications on news.